- Home
- WDH vs KROS Comparison
WDH vs KROS Comparison
Compare WDH & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WDH | KROS |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 647.4M | 655.9M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | WDH | KROS |
|---|---|---|
| Price | $1.73 | $18.72 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | 334.6K | ★ 365.3K |
| Earning Date | 03-11-2026 | 02-25-2026 |
| Dividend Yield | ★ 3.51% | N/A |
| EPS Growth | ★ 75.20 | N/A |
| EPS | 0.20 | ★ 1.57 |
| Revenue | ★ $456,980,701.00 | $246,718,000.00 |
| Revenue This Year | N/A | $6,924.79 |
| Revenue Next Year | $12.60 | N/A |
| P/E Ratio | ★ $8.70 | $12.19 |
| Revenue Growth | 18.55 | ★ 37798.31 |
| 52 Week Low | $1.08 | $9.12 |
| 52 Week High | $2.18 | $22.55 |
Technical Indicators
Market Signals| Indicator | WDH | KROS |
|---|---|---|
| Relative Strength Index (RSI) | 38.14 | 45.86 |
| Support Level | $1.71 | $18.33 |
| Resistance Level | $1.85 | $19.94 |
| Average True Range (ATR) | 0.06 | 0.67 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 4.35 | 51.85 |
Price Performance
Historical ComparisonAbout WDH Waterdrop Inc. (each representing the right to receive 10)
Waterdrop Inc is a technology platform dedicated to insurance and healthcare service. The Company is mainly engaged in operating an independent third-party insurance platform dedicated to providing insurance and healthcare service. The Company's main businesses are the insurance marketplace, medical crowdfunding, and mutual aid. The insurance marketplace business is collaborated with insurance carriers to offer health and life insurance products to ensure a smooth and friendly user experience throughout the process from underwriting to claim services. The medical crowdfunding business enabled people with medical costs.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.